Global Stem Cell Manufacturing Market is Growing with a CAGR of 10.1% in the Forecast Period of 2021 to 2028

Global Stem Cell Manufacturing Market is growing with factors such as rising prevalence of cancer and stem cell transplant for cancer treatment, rising research and development activities along with government support, rising collaborations among key market players among others. The large number of pipeline products is also propelling the demand of the market.

Technological advancements have propelled the demand of the market. However, the side effects of therapy along with high cost have decreased the demand of the market.

Global Stem Cell Manufacturing Market Scenario                   

According to Data Bridge Market Research, the market for global stem cell manufacturing in North America has the highest market share followed by Europe and Asia-Pacific. Market leader is Thermo Fisher Scientific, Inc. which accounts an estimated market share of approximately 16.72% in the global market. The company has gained outstanding sale by providing novel technology stem cell based products.

• In January 2021, Thermo Fisher Scientific Inc. launched new medium for the development of human T lymphocytes for allogenic cell therapy. The media solution targets the metabolism of healthy donor cells and making it ideal for use in the production of allogenic cell therapies. This will help the company for research use or manufacturing of cell, gene or tissue based products. However, it is not intended for direct administration to humans.

Trends Impacting the Market

Now the question is which other regions Thermo Fisher Scientific, Inc., TAKEDA Pharmaceutical Co., Ltd., Merck KGaA are targeting? Data Bridge Market Research has forecasted a large growth in North America stem cell manufacturing market and the market leaders targeting U.S. and Canada to be their next pocket revenue for 2021.

The stem cell manufacturing market is becoming more competitive with companies Thermo Fisher Scientific Inc., TAKEDA Pharmaceutical Co., Ltd., and Merck KGaA as they are the market leaders for global stem cell manufacturing market. The Data Bridge Market Research new reports highlight the major growth factors and opportunities in the global stem cell manufacturing market.

For more analysis on the global stem cell manufacturing market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-stem-cell-manufacturing-market

Gene Stem Cell Manufacturing Developments

• In June 2021, Catalent Inc. announced that is has acquired RheinCell Therapeuics which is a  manufaxcturer of human induced pluripotent stem cells. This will help the company to build up the company’s existing custom cell herapy process development.
• In May 2021, REPROCELL Inc. announced that it has renewed its agreement with VIROCLINICS-DDL. Under agreement REPROCELL will provide sample processing services to VIROCLINICS-DDL in order to support clinical research products. This will help the company to further expand its business.

Scope of the Stem Cell Manufacturing Market

Global stem cell manufacturing market is segmented on the basis of countries into the U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Switzerland, Russia, Netherlands, Belgium, Ireland, Turkey, Rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Philippines, Indonesia, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Israel, Egypt and Rest of Middle East and Africa.

All country based analysis of the global stem cell manufacturing market is further analysed based on maximum granularity into further segmentation. On the basis of products, global stem cell manufacturing market is segmented into stem cell lines, instruments, consumables & kits. On the basis of application, global stem cell manufacturing market is segmented into research applications, clinical applications, cell and tissue banking and others. On the basis of end user, global stem cell manufacturing market is segmented into biotechnology & pharmaceutical companies, research institutes and academic institutes, cell banks and tissue banks, hospital & surgical centers and others. On the basis of distribution channel, global stem cell manufacturing market is segmented into direct sales and third party distributors.

To know more about the study https://www.databridgemarketresearch.com/reports/global-stem-cell-manufacturing-market

Key Pointers Covered in Stem Cell Manufacturing Market Industry Trends and Forecast to 2028

• Market Size
• Top to Bottom Market Analysis
• Recent Developments for Market Competitors
• Recent Market Value for Different Countries
• Market value and over view of stem cell manufacturing market
• Company profiling of top eight players of stem cell manufacturing market

Key Market Competitors Covered in the Report

• Thermo Fisher Scientific Inc.,
•  Merck KGaA,
• BD,
• Organogenesis Inc.,
• Vericel Corporation,
• ANTEROGEN. CO., LTD.,
• VistaGen Therapeutics, Inc.,
• FUJIFILM Cellular Dynamics, Inc.,
• American CryoSystem Corporation,
• PromoCell GmbH,
• Sartorius AG, ViaCyte, Inc.,
• STEM CELL Technologies, Inc.,
• Takeda Pharmaceutical Company Limited,
• DAIICHI SANKYO COMPANY, LIMITED,
• Bio-Techne,
• REPROCELL Inc.,
• Catalent, Inc,
• Mesoblast Ltd,
• Astellas Pharma Inc. among others.

Above are the key players covered in the report, to know about more and exhaustive list of stem cell manufacturing companies’, contact us https://www.databridgemarketresearch.com/toc/?dbmr=global-stem-cell-manufacturing-market

Research Methodology: Global Stem  Cell Manufacturing Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

• Demand Side: Manufacturer, Geneticists, Healthcare Industry, Scientists, Research Laboratories
• Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

• Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market
• Global Cord Stem Cell Banking Market
• Global Stem Cell Banking Market

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/